CALB2 and sarcoma: The expression of calretinin to varying degrees was observed in about 3/4 of CIC sarcomas, emphasizing that ETV4 has a positive expression rate of 70% in CIC-NUTM1 sarcomas, which is inconsistent with classical CIC sarcomas (positive rate of up to 100%).